Cytek Biosciences, Inc. CTKB Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s retained earnings?
- Cytek Biosciences, Inc. (CTKB) reported retained earnings of -$120.6M in Q1 2026.
- How has Cytek Biosciences, Inc.'s retained earnings changed year-over-year?
- Cytek Biosciences, Inc.'s retained earnings decreased by 158.8% year-over-year, from -$46.6M to -$120.6M.
- What is the long-term trend for Cytek Biosciences, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s retained earnings has grown at a 35.1% compound annual growth rate (CAGR), from -$22.61M to -$101.74M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.